NDLI: A case series of ten plus one deficiency of adenosine deaminase 2 (DADA2) patients in Iran

Content Provider	Springer Nature : BioMed Central
Author	Asna Ashari, Kosar Aslani, Nahid Parvaneh, Nima Assari, Raheleh Heidari, Morteza Fathi, Mohammadreza Tahghighi Sharabian, Fatemeh Ronagh, Alireza Shahrooei, Mohammad Moafi, Alireza Rezaei, Nima Ziaee, Vahid
Abstract	Background Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive autoinflammatory disease caused by mutations in the ADA2 gene. DADA2 has a broad spectrum of clinical presentations. Apart from systemic manifestations, we can categorize most of the signs and symptoms of DADA2 into the three groups of vasculitis, hematologic abnormalities, and immunologic dysregulations. The most dominant vasculitis features are skin manifestations, mostly in the form of livedo racemosa/reticularis, and early onset ischemic or hemorrhagic strokes. Hypogammaglobulinemia that is found in many cases of DADA2 brings immunodeficiencies into the differential diagnosis. Cytopenia, pure red cell aplasia (PRCA), and bone marrow failure (BMF) are the hematologic abnormalities commonly found in DADA. Case presentation We introduce eleven patients with DADA2 diagnosis, including two brothers and sisters, one set of twin sisters, and one father and his daughter and son. Ten patients (91%) had consanguineous parents. All the patients manifested livedo racemose/reticularis. Ten patients (91%) reported febrile episodes, and seven (64%) had experienced strokes. Only one patient had hypertension. Two of the patients (11%) presented decreased immunoglobulin levels. One of the patients presented with PRCA. Except for the PRCA patient with G321E mutation, all of our patients delivered G47R mutation, the most common mutation in DADA2 patients. Except for one patient who unfortunately passed away before the diagnosis was made and proper treatment was initiated, the other patients’ symptoms are currently controlled; two of the patients presented with mild symptoms and are now being treated with colchicine, and the eight others responded well to anti-TNFs. The PRCA patient still suffers from hematologic abnormalities and is a candidate for a bone marrow transplant. Conclusions Considering the manifestations and the differential diagnoses, DADA2 is not merely a rheumatologic disease, and introducing this disease to hematologists, neurologists, and immunologists is mandatory to initiate prompt and proper treatment. The efficacy of anti-TNFs in resolving the symptoms of DADA2 patients have been proven, but not for those with hematologic manifestations. Similarly, they were effective in controlling the symptoms of our cohort of patients, except for the one patient with cytopenia.
Related Links	https://ped-rheum.biomedcentral.com/counter/pdf/10.1186/s12969-023-00838-3.pdf
Ending Page	8
Page Count	8
Starting Page	1
File Format	HTM / HTML
ISSN	15460096
DOI	10.1186/s12969-023-00838-3
Journal	Pediatric Rheumatology
Issue Number	1
Volume Number	21
Language	English
Publisher	BioMed Central
Publisher Date	2023-06-13
Access Restriction	Open
Subject Keyword	Pediatrics Rheumatology Deficiency of adenosine deaminase 2 DADA2 Autoinflammatory syndrome Livedo racemosa
Content Type	Text
Resource Type	Case study
Subject	Immunology and Allergy Pediatrics, Perinatology and Child Health Rheumatology
Journal Impact Factor	2.8/2023
5-Year Journal Impact Factor	2.8/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2)

B cells characterization in ADA2 Deficiency patients

Clinical follow-up on a cohort of patients with deficiency of adenosine deaminase 2 (DADA2)

Clinical follow-up on a cohort of patients with deficiency of adenosine deaminase 2 (DADA2)

Diagnosis and management of adenosine deaminase 2 deficiency children: the experience from China

A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2)

Deficiency of Adenosine Deaminase 2 (DADA2): One Disease, Several Faces.

A case series of adenosine deaminase 2 deficient patients emphasizing treatment and genotype-phenotype correlations

A case series of adenosine deaminase 2 deficient patients emphasizing treatment and genotype-phenotype correlations

A case series of ten plus one deficiency of adenosine deaminase 2 (DADA2) patients in Iran

Similar Documents

Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2)

B cells characterization in ADA2 Deficiency patients

Clinical follow-up on a cohort of patients with deficiency of adenosine deaminase 2 (DADA2)

Clinical follow-up on a cohort of patients with deficiency of adenosine deaminase 2 (DADA2)

Diagnosis and management of adenosine deaminase 2 deficiency children: the experience from China

A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2)

Deficiency of Adenosine Deaminase 2 (DADA2): One Disease, Several Faces.

A case series of adenosine deaminase 2 deficient patients emphasizing treatment and genotype-phenotype correlations

A case series of adenosine deaminase 2 deficient patients emphasizing treatment and genotype-phenotype correlations

A case series of ten plus one deficiency of adenosine deaminase 2 (DADA2) patients in Iran